BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 8133532)

  • 1. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
    Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
    J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
    J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses.
    Studentsov YY; Ho GY; Marks MA; Bierman R; Burk RD
    J Clin Microbiol; 2003 Jul; 41(7):2827-34. PubMed ID: 12843008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies.
    Hernandez BY; Ton T; Shvetsov YB; Goodman MT; Zhu X
    Clin Vaccine Immunol; 2012 Sep; 19(9):1348-52. PubMed ID: 22761294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
    Heim K; Christensen ND; Höpfl R; Wartusch B; Zeimet A; Larcher C; Ruth N; Bergant A; Pirschner G; Dierich MP
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():25-31. PubMed ID: 8672922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: correlation with virus-like particle IgG concentration.
    Bryan JT; Jansen KU; Lowe RS; Fife KH; McClowry T; Glass D; Brown DR
    J Med Virol; 1997 Nov; 53(3):185-8. PubMed ID: 9365880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.
    Sehr P; Müller M; Höpfl R; Widschwendter A; Pawlita M
    J Virol Methods; 2002 Oct; 106(1):61-70. PubMed ID: 12367730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A; Gómez-Lim MA; Weiss-Steider B; la Rosa GP; Hernández-Montes J; Pérez-Saldaña K; Tapia-Guerrero YS; Toledo-Guzmán ME; Santiago-Osorio E; Sanchez-Peña HI; Mora-García Mde L
    Virol J; 2011 Feb; 8():59. PubMed ID: 21306638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillomavirus-like particles for serology and vaccine development.
    Kirnbauer R
    Intervirology; 1996; 39(1-2):54-61. PubMed ID: 8957670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
    Marais DJ; Rose RC; Lane C; Kay P; Nevin J; Denny L; Soeters R; Dehaeck CM; Williamson AL
    J Med Virol; 2000 Apr; 60(4):403-10. PubMed ID: 10686023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.
    Le Cann P; Touze A; Enogat N; Leboulleux D; Mougin C; Legrand MC; Calvet C; Afoutou JM; Coursaget P
    J Clin Microbiol; 1995 May; 33(5):1380-2. PubMed ID: 7615761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IgG, IgM, and IgA reactivity to human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups.
    Heim K; Christensen ND; Hoepfl R; Wartusch B; Pinzger G; Zeimet A; Baumgartner P; Kreider JW; Dapunt O
    J Infect Dis; 1995 Aug; 172(2):395-402. PubMed ID: 7542685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
    J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
    Sasagawa T; Inoue M; Lehtinen M; Zhang W; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):403-10. PubMed ID: 8807204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
    Nonnenmacher B; Kruger Kjaer S; Svare EI; Scott JD; Hubbert NL; van den Brule AJ; Kirnbauer R; Walboomers JM; Lowy DR; Schiller JT
    Int J Cancer; 1996 Dec; 68(6):704-9. PubMed ID: 8980170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D; Rose RC; Williamson AL
    J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
    Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
    J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
    Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
    J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.